let therapy (vs monotherapy) and actually
advised against it owing to an increased bleeding risk.
A meta-analysis examining the impact of more intense
low-density lipoprotein cholesterol-lowering strategies
reported that all-cause mortality was decreased by 10%,
largely from deaths owing to coronary heart disease, for
each 1 mmol/L reduction in low-density lipoprotein
cholesterol (RR, 0.90; 95% CI, 